Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Raimonda Kubiliute, Algirdas Zalimas, Arnas Bakavicius, Albertas Ulys, Feliksas Jankevicius & Sonata Jarmalaite. (2021) Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma. OncoTargets and Therapy 14, pages 4979-4990.
Read now
Read now
Feifei Liang, Rensheng Wang, Qinghua Du & Shangyong Zhu. (2021) An Epithelial–Mesenchymal Transition Hallmark Gene-Based Risk Score System in Head and Neck Squamous-Cell Carcinoma. International Journal of General Medicine 14, pages 4219-4227.
Read now
Read now
Articles from other publishers (30)
Menghan Zhou, Shenling Yu, Yue Liu, Shihui Shu, Ying Xu, Min Liu, Yanping Ge & Hong Fan. (2023) H3K27me3 Inactivates SFRP1 to Promote Cell Proliferation via Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences.
Crossref
Crossref
Lei Dong, Qi Sun, Fei Song, Xiaoyu Song, Congxian Lu, Yumei Li & Xicheng Song. (2023) Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Heliyon 9:3, pages e14003.
Crossref
Crossref
Maximilian Hauschulz, Sophia Villwock, Jennifer Kosinski, Florian Steib, Lara Rosaline Heij, Jan Bednarsch, Ruth Knüchel-Clarke & Edgar Dahl. (2023) Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers 15:3, pages 683.
Crossref
Crossref
Zhi Chen, Zuan Li, Chunlin Li, Bingcai Li, Haojian Wang, Deyong Nong, Ximing Li, Guihai Huang, Junhao Lin & Wei Li. (2022) Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma. BMC Cancer 22:1.
Crossref
Crossref
P. Vijayaragavan, M.A. Rathi, V.K. Gopalakrishnan, Rami Adel Pashameah, Atif Abdulwahab A. Oyouni, Osama M. Al-Amer, Waseem AlZamzami, Hussam Awwadh E. Althagafi, V. Duraipandiyan & Fahad Alharthi. (2022) CpG methylation analysis of tumour suppressor gene and expression of Cathepsin B in renal cell carcinoma. Journal of King Saud University - Science 34:8, pages 102330.
Crossref
Crossref
Jürgen Serth, Inga Peters, Olga Katzendorn, Tu N. Dang, Joana Moog, Zarife Balli, Christel Reese, Jörg Hennenlotter, Alexander Grote, Marcel Lafos, Hossein Tezval & Markus A. Kuczyk. (2022) Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS). International Journal of Molecular Sciences 23:19, pages 11190.
Crossref
Crossref
Jürgen Serth, Inga Peters, Bastian Hill, Tatjana Hübscher, Jörg Hennenlotter, Michael Klintschar & Markus Antonius Kuczyk. (2022) Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes. International Journal of Molecular Sciences 23:10, pages 5327.
Crossref
Crossref
Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Joana M. Moog, Christel Reese, Hossein Tezval, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk & Jürgen Serth. (2021) DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma. Cancers 14:1, pages 39.
Crossref
Crossref
Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Hossein Tezval, Pouriya Faraj Tabrizi, Christoph A. von Klot, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk & Jürgen Serth. (2021) DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers. BMC Cancer 21:1.
Crossref
Crossref
Yongke You, Yeping Ren, Jikui Liu & Jianhua Qu. (2021) Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma. Frontiers in Genetics 12.
Crossref
Crossref
Amrit L. Pappula, Shayaan Rasheed, Golrokh Mirzaei, Ruben C. Petreaca & Renee A. Bouley. (2021) A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database. Cancers 13:17, pages 4299.
Crossref
Crossref
Yong-Bo Chen, Liang Gao, Jin-Dong Zhang, Jiang Guo, Ping-Hong You, Liang-You Tang & Ying-Wen Liu. (2021) Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma. BioMed Research International 2021, pages 1-18.
Crossref
Crossref
Javier C. Angulo, Claudia Manini, Jose I. López, Angel Pueyo, Begoña Colás & Santiago Ropero. (2021) The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments. Cancers 13:9, pages 2071.
Crossref
Crossref
Jürgen Serth, Inga Peters, Natalia Dubrowinskaja, Christel Reese, Knut Albrecht, Michael Klintschar, Marcel Lafos, Alexander Grote, Albert Becker, Jörg Hennenlotter, Arnulf Stenzl, Hossein Tezval & Markus A. Kuczyk. (2020) Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue. Clinical Epigenetics 12:1.
Crossref
Crossref
Pengfei Liu & Weidong Tian. (2020) Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis. PeerJ 8, pages e9654.
Crossref
Crossref
Ivonne Regel, Melanie Eichenmüller, Ujjwal Mukund Mahajan, Beate Hagl, Simone Benitz, Beate Häberle, Christian Vokuhl, Dietrich von Schweinitz & Roland Kappler. (2020) Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Journal of Cancer Research and Clinical Oncology 146:5, pages 1153-1167.
Crossref
Crossref
Inga Peters, Axel S. Merseburger, Hossein Tezval, Marcel Lafos, Pouriya Faraj Tabrizi, Mehrdad Mazdak, Mathias Wolters, Markus A. Kuczyk, Jürgen Serth & Christoph-A.J. von Klot. (2020) The Prognostic Value of DNA Methylation Markers in Renal Cell Cancer: A Systematic Review. Kidney Cancer 4:1, pages 3-13.
Crossref
Crossref
Rashidah Baharudin, Francis Yew Fu Tieng, Learn-Han Lee & Nurul Syakima Ab Mutalib. (2020) Epigenetics of SFRP1: The Dual Roles in Human Cancers. Cancers 12:2, pages 445.
Crossref
Crossref
Qiong-Ni Zhu, Helen Renaud & Ying Guo. (2018) Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy. Hereditas 155:1.
Crossref
Crossref
Sophie C. Joosten, Kim M. Smits, Maureen J. Aarts, Veerle Melotte, Alexander Koch, Vivianne C. Tjan-Heijnen & Manon van Engeland. (2018) Epigenetics in renal cell cancer: mechanisms and clinical applications. Nature Reviews Urology 15:7, pages 430-451.
Crossref
Crossref
Shijie Mo, Zexuan Su, Baoli Heng, Weijun Chen, Liping Shi, Xinghua Du & Caiyong Lai. (2018) SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis. Journal of Nippon Medical School 85:2, pages 78-86.
Crossref
Crossref
Julia Mendoza-Pérez, Jian Gu, Luis A. Herrera, Nizar M. Tannir, Shanyu Zhang, Surena Matin, Jose A. Karam, Christopher G. Wood & Xifeng Wu. (2017) Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma. Cancer 123:18, pages 3617-3627.
Crossref
Crossref
Sophie C Joosten, Ivette AG Deckers, Maureen J Aarts, Ann Hoeben, Joep G van Roermund, Kim M Smits, Veerle Melotte, Manon van Engeland & Vivianne C Tjan-Heijnen. (2017) Prognostic DNA methylation markers for renal cell carcinoma: a systematic review. Epigenomics 9:9, pages 1243-1257.
Crossref
Crossref
S.C. Joosten, L. Hamming, P.M. Soetekouw, M.J. Aarts, J. Veeck, M. van Engeland & V.C. Tjan-Heijnen. (2015) Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:1, pages 1-16.
Crossref
Crossref
Mukesh Verma. 2015. Advances in Cancer Biomarkers. Advances in Cancer Biomarkers
59
80
.
Clara Dees, Inga Schlottmann, Robin Funke, Alfiya Distler, Katrin Palumbo-Zerr, Pawel Zerr, Neng-Yu Lin, Christian Beyer, Oliver Distler, Georg Schett & Jörg H W Distler. (2014) The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Annals of the Rheumatic Diseases 73:6, pages 1232-1239.
Crossref
Crossref
INGA PETERS, KAI GEBAUER, NATALIA DUBROWINSKAJA, FARANAZ ATSCHEKZEI, MARIO W. KRAMER, JOERG HENNENLOTTER, HOSSEIN TEZVAL, MAHMOUD ABBAS, RALPH SCHERER, AXEL S. MERSEBURGER, ARNULF STENZL, MARKUS A. KUCZYK & JUERGEN SERTH. (2014) GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma. Oncology Reports 31:4, pages 1523-1530.
Crossref
Crossref
Natalia Dubrowinskaja, Kai Gebauer, Inga Peters, Jörg Hennenlotter, Mahmoud Abbas, Ralph Scherer, Hossein Tezval, Axel S. Merseburger, Arnulf Stenzl, Viktor Grünwald, Markus A. Kuczyk & Jürgen Serth. (2014)
Neurofilament Heavy polypeptide
CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
. Cancer Medicine 3:2, pages 300-309.
Crossref
Crossref
Dan Lu, Dong Dong, Yu Zhou, Min Lu, Xue-Wen Pang, Yan Li, Xiao-Jun Tian, Yu Zhang & Jun Zhang. (2013)
The Tumor-Suppressive Function of
UNC5D
and Its Repressed Expression in Renal Cell Carcinoma
. Clinical Cancer Research 19:11, pages 2883-2892.
Crossref
Crossref
K Gebauer, I Peters, N Dubrowinskaja, J Hennenlotter, M Abbas, R Scherer, H Tezval, A S Merseburger, A Stenzl, M A Kuczyk & J Serth. (2013) Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma. British Journal of Cancer 108:1, pages 131-138.
Crossref
Crossref